Patients with myelodysplastic syndromes (MDS) challenge transfusion resources now and in the future

被引：0
作者：
Plesnila-Frank, C. [1 ]
Rottenkolber, D. [2 ]
Berger, K. [2 ]
机构：
[1] Med Econ Res Grp, Munich, Germany
[2] Univ Hosp Munich, Munich, Germany
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)65041-3
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A283 / A284
页数：2
相关论文
共 50 条
[41]   Clinical Experience of Decitabine in Elderly Patients with Myelodysplastic Syndromes (MDS) [J].
Geils, George F., Jr. .
BLOOD, 2009, 114 (22) :1092-1092
[42]   Improvement in cytopenias of patients with myelodysplastic syndromes (MDS) in response to thalidomide [J].
Raza, A ;
Lisak, L ;
Little, L ;
Andrews, C ;
Meyer, P ;
Ekbal, M ;
Venugopal, P .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (07) :103-104
[43]   THE IMPACT OF MYELODYSPLASTIC SYNDROMES (MDS) ON THE MENTAL HEALTH OF PATIENTS AND CAREGIVERS [J].
Scheurmeyer, Isabel ;
Hughes, Mary ;
Sloan, Erika ;
LeBlanc, Thomas ;
Houk, Alice ;
Sirewu, Nyaradzo .
ONCOLOGY NURSING FORUM, 2024, 51 (02)
[44]   Combination of thalidomide and Enbrel for the treatment of patients with myelodysplastic syndromes (MDS). [J].
Raza, A ;
Dutt, D ;
Lisak, L ;
Dean, L ;
Fantroy, L ;
Gezer, S ;
Syed, E ;
Goldberg, C ;
Loew, J ;
Hsu, WT ;
Venugopal, P .
BLOOD, 2001, 98 (11) :273B-274B
[45]   CLASSIFICATION AND TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) [J].
CATOVSKY, D .
MYELODYSPLASTIC SYNDROMES : PATHOPHYSIOLOGY AND TREATMENT, 1988, 783 :3-3
[46]   PROGNOSTIC FACTORS IN MYELODYSPLASTIC SYNDROMES (MDS) [J].
TRICOT, G ;
VLIETINCK, R ;
HENDRICKX, B ;
VERWILGHEN, RL .
BRITISH JOURNAL OF HAEMATOLOGY, 1985, 60 (02) :362-362
[47]   IMMUNOTHERAPY STRATEGIES IN MYELODYSPLASTIC SYNDROMES (MDS) [J].
Gill, Saar .
LEUKEMIA RESEARCH, 2021, 108 :S57-S57
[48]   RISK ASSESSMENT IN MYELODYSPLASTIC SYNDROMES (MDS) [J].
Improta, S. ;
Gagliardi, A. ;
Lucania, A. ;
Della Cioppa, P. ;
Villa, M. R. ;
Esposito, M. ;
Quirino, A. ;
Mastrullo, L. .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 :556-557
[49]   Cyclosporin A in the treatment of myelodysplastic syndromes (MDS) [J].
Shirin, AD ;
Volkova, MA .
EUROPEAN JOURNAL OF CANCER, 1997, 33 :416-416
[50]   Iron overload in myelodysplastic syndromes (MDS) [J].
Norbert Gattermann .
International Journal of Hematology, 2018, 107 :55-63
12345